For patients with chronic hepatitis B (CHB) virus, development of diabetes is an independent risk factor for hepatocellular carcinoma (HCC), HCC-related mortality, and all-cause mortality, according to results published in the Journal of Viral Hepatology.

The study included participants with CHB who were newly diagnosed with diabetes in 2000 from the Longitudinal Cohort of Diabetes Patients database (n = 2966). The researchers used propensity scores matching based on age, gender, alcohol-related liver disease, and baseline liver cirrhosis to compare data from study participants with data from people with CHB without diabetes from the Taiwanese National Health Insurance Research Database (n = 2966).

During 11 years of follow-up, HCC developed in 11.8% of participants (n = 708), 12.3% (n = 731) of participants had all-cause mortality, and 6.1% (n = 363) of participants had HCC-related mortality.


Continue Reading

Compared with participants without diabetes, participants with diabetes had significantly higher risk for HCC development (13.3% vs 10%; P <.001) and HCC-related mortality (7.5% vs 4.7%; P <.001). Participants with diabetes also had a significantly higher rate of all-cause mortality (16.9%) compared with participants without diabetes (8.2%; P <.001).

Related Articles

Using a multivariable transition-specific Cox model, the researchers determined that diabetes was a significant independent risk factor for HCC development (hazard ratio [HR] 1.35; 95% CI, 1.16-1.57; P <.001). They also found that diabetes was significantly, independently associated with HCC-related mortality (HR, 1.31; 95% CI, 1.06-1.62; P =.014) and all-cause mortality (HR, 2.32; 95% CI, 1.84-2.92; P <.001).

“These findings provide new support for adopting aggressive therapy for HCC and strict [diabetes] control for such patients,” the researchers wrote.

Follow @EndoAdvisor

Reference

Shyu Y, Huang T, Chien C, Yeh C, Lin C, Chien R. Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: a population-based cohort study [published online February 9, 2019]. J Viral Hepat. doi:10.1111/jvh.13077

This article originally appeared on Infectious Disease Advisor